{
    "clinical_study": {
        "@rank": "16592", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "Genetic counseling", 
                "arm_group_type": "Experimental", 
                "description": "After randomization the participant is offered a referral to a genetic counselor."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to evaluate the effect of systematic identification and\n      genetic counseling referral on rates of bilateral salpingo-oophorectomy (surgery to remove\n      both fallopian tubes and ovaries) in women having mammograms at Swedish Medical Center in\n      Seattle, WA."
        }, 
        "brief_title": "Prevention of Ovarian Cancer in Women Participating in Mammography", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Epithelial Ovarian Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Ovarian Neoplasms", 
                "Neoplasms, Glandular and Epithelial"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Prior mammogram at Swedish Medical Center\n\n          -  Willing and able to provide informed consent, primary physician information,   and\n             complete study questionnaires\n\n          -  Must meet at least ONE of the following criteria:\n\n          -  personal history of breast cancer diagnosed before age 50\n\n          -  personal history of bilateral breast cancer at any age\n\n          -  1 or more first degree relatives with breast cancer diagnosed before age 50\n\n          -  3 or more first or second degree relatives with breast cancer at any age\n\n          -  2 second degree relatives with breast cancer diagnosed before age 50\n\n          -  A male relative with breast cancer at any age\n\n          -  Ashkenazi Jewish with any family history of breast or ovarian cancer\n\n          -  1 first or second degree relative with ovarian cancer AND 1 first or second degree\n             relative with breast cancer at any age\n\n          -  2 first degree relatives with ovarian cancer or 2 second degree relatives with\n             ovarian cancer or 1 first and 1 second degree relative with ovarian cancer.\n\n          -  A first degree relative with both breast and ovarian cancer (2 primaries in the same\n             person)\n\n          -  Personal history of positive genetic test result for any of the following genes:\n             BRCA1, BRCA2, HNPCC, or P53\n\n          -  Family history of a positive genetic test result for any of the following genes:\n             BRCA1, BRCA2 or HNPCC\n\n        Exclusion Criteria:\n\n          -  Previous diagnosis of ovarian cancer\n\n          -  Prior bilateral-salpingo oophorectomy\n\n          -  Had a negative genetic test result for a known family genetic mutation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "458", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851109", 
            "org_study_id": "1R18DP001142-01"
        }, 
        "intervention": {
            "arm_group_label": "Genetic counseling", 
            "description": "The genetic counseling sessions are conducted by a licensed genetic counselor, certified by the American Board of Genetic Counseling and the American Board of Medical Genetics. This clinical counseling session may include, but is not limited to the following:\nA review of medical and family history information to determine which genetic test (BRCA, HNPCC, p53, etc.), if any, is appropriate;\nDiscuss how the results - positive or negative - affect cancer risk\nDiscuss how cancer risk might be managed (surveillance, prophylactic surgery, oral contraceptives, etc.);\nDiscuss how the test is conducted and what the results might be (positive, negative, uncertain);\nDiscuss the disadvantages of genetic testing (cost, insurance coverage, worry about insurance discrimination, uncertain results, etc.) and the psychological and emotional issues surrounding testing, etc.", 
            "intervention_name": "genetic counseling", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ovarian cancer", 
            "prevention", 
            "prophylactic surgery", 
            "risk", 
            "biomarkers", 
            "screening", 
            "symptoms"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98109"
                }, 
                "name": "Fred Hutchinson Cancer Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prevention of Ovarian Cancer in Women Participating in Mammography", 
        "overall_official": {
            "affiliation": "Fred Hutchinson Cancer Research Center", 
            "last_name": "Nicole Urban, ScD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Federal Government"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Compare rates of risk-reducing salpingo-oophorectomy in each of the study arms", 
            "safety_issue": "No", 
            "time_frame": "24 months post-enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851109"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Cancer related distress", 
                "safety_issue": "Yes", 
                "time_frame": "change from baseline at 12 and 24 months post-enrollment"
            }, 
            {
                "measure": "Health-related quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "change from baseline at 12 and 24 months post-enrollment"
            }
        ], 
        "source": "Fred Hutchinson Cancer Research Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Swedish Medical Center", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Fred Hutchinson Cancer Research Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}